MedTrace Logo

Probiotics for Depressive Symptomatology and Neural Activity.

NCT07667530 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-06-25

No results posted yet for this study

Summary

This study aims to investigate the acute and chronic effects of 16-week probiotic supplementation (Ecologic® Barrier) on depressive symptoms and neural activity in those with mild-to-moderate depression.

Conditions

  • Mild-to-moderate Depression
  • Neural Activity
  • Executive Function (Cognition)

Interventions

DIETARY_SUPPLEMENT

Ecologic® Barrier

Ecologic® Barrier (1x1010 CFU/day).

DIETARY_SUPPLEMENT

Placebo powder

Matched placebo

Sponsors & Collaborators

  • Winclove Probiotics B.V.

    collaborator INDUSTRY

  • University of Reading

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-03-01
Completion
2027-03-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07667530 on ClinicalTrials.gov